Back
Medtronic PLC 10K Form
Buy
63
MDT
Medtronic PLC
Last Price:
86.18
Seasonality Move:
5.66%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-06-20 | 10K | MDT/Medtronic PLC Annual |
2024-02-27 | 10Q | MDT/Medtronic PLC Quarterly |
2023-11-30 | 10Q | MDT/Medtronic PLC Quarterly |
2023-08-31 | 10Q | MDT/Medtronic PLC Quarterly |
2023-06-22 | 10K | MDT/Medtronic PLC Annual |
2023-03-01 | 10Q | MDT/Medtronic PLC Quarterly |
Receive MDT News And Ratings
See the #1 stock for the next 7 days that we like better than MDT
MDT Financial Statistics
Sales & Book Value
Annual Sales: | $32.36B |
---|---|
Cash Flow: | $554M |
Price / Cash Flow: | 20.53 |
Annual Sales: | $37.81 |
Price / Book: | 2.28 |
Profitability
EPS (TTM): | 3.27000 |
---|---|
Net Income (TTM): | $4.29B |
Gross Margin: | $21.15B |
Return on Equity: | 8.54% |
Return on Assets: | 4.76% |
Medtronic PLC Earnings Forecast
Key Medtronic PLC Financial Ratios
- The Gross Profit Margin over the past 41 years for MDT is 65.34%.
- The Selling, General & Administrative Expenses for MDT have been equal to 33.17% of Gross Profit Margin.
- The Research & Development expenses have been 8.45% of Revenue.
- The Interest Expense is 19.56% of Operating Income.
- The Net Earning history of MDT is 11.36% of Total Revenues.
- Per Share Earnings over the last 41 years have been positive in 26 years.
Medtronic PLC Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | MDT |
CUSIP: | G5960L |
Website: | medtronic.com |
Debt
Debt-to-Equity Ratio: | 0.58 |
---|---|
Current Ratio: | 1.84 |
Quick Ratio: | 1.17 |
Price-to-Earnings
Trailing P/E Ratio: | 31.24 |
---|---|
Forward P/E Ratio: | 14.76 |
MDT Technical Analysis vs Fundamental Analysis
Buy
63
Medtronic PLC (MDT)
is a Buy
Is Medtronic PLC a Buy or a Sell?
-
Medtronic PLC stock is rated a Buy
The current Medtronic PLC [MDT] share price is $86.21. The Score for MDT is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.